UK's Vaccine Rollout Exceeds European Peers Despite Brexit Fears

Strategic Insights -

The United Kingdom's pandemic response received a boost from a remarkable vaccine rollout, which has resulted in more than 18.5 million doses being administered, or 27 per 100 people, exceeding its European Union counterparts. The UK's rapid vaccine procurement and approval process, despite being a non-EU member, allowed it to outpace its European partners. The country's decision to prioritize the Oxford-AstraZeneca vaccine, developed in partnership with the University of Oxford, has been vindicated by recent research showing the vaccine's effectiveness in reducing hospitalizations.

Key Takeaways:

  • The UK has administered over 18.5 million vaccine doses, with a rate of 27 per 100 people, surpassing EU giants France and Germany, which have managed only six per 100.
  • The UK's rapid vaccine rollout was facilitated by its decision to not work with the EU in procurement and approval, allowing for quicker negotiations and authorization.
  • The Oxford-AstraZeneca vaccine, developed in partnership with the University of Oxford, was the first to be authorized for use in all adults in the UK and has shown significant effectiveness in reducing hospitalizations.
  • European regulators are reconsidering their restrictions on the vaccine's use, following the publication of a Scottish study showing its high effectiveness in preventing hospitalizations, including in elderly populations.
  • The EU's battle with AstraZeneca over delayed vaccine supply and public confidence concerns has hindered its own vaccine rollout, with some countries struggling to convince citizens to take the shot.
  • European officials are criticizing the EU for its handling of the vaccine rollout, citing a lack of transparency and cohesion in the decision-making process.

Statistics:

  • Over 18.5 million vaccine doses have been administered in the UK.
  • The UK's vaccine rate is 27 per 100 people.
  • France and Germany have administered only 6 per 100 vaccine doses each.
  • European regulators are reconsidering their restrictions on the AstraZeneca vaccine's use.
  • The UK has purchased 357 million vaccines, with the largest contract being with AstraZeneca.
  • The AstraZeneca vaccine has been shown to be 94% effective in reducing hospitalizations four weeks after a single dose.

Sources:

  • CNN - https://www.cnn.com/
  • Reuters - https://www.reuters.com/
  • University of Oxford - [No specific date]
  • European Parliament - [No specific date]
  • European Union - [No specific date]
  • AstraZeneca - [No specific date]